Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.69
-0.29 (-1.16%)
At close: Apr 28, 2026, 4:00 PM EDT
24.69
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:15 PM EDT
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $748.01 million as of April 28, 2026. Its market cap has increased by 34.36% in one year.
Market Cap
748.01M
Enterprise Value
483.09M
1-Year Change
34.36%
Ranking
Category
Stock Price
$24.69
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $748.01M, an increase of 507.88%. That is a compound annual growth rate of 30.59%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.69B |
| GRAIL | 2.26B |
| GeneDx Holdings | 1.94B |
| NeoGenomics | 1.12B |
| CareDx | 1.12B |
| OPKO Health | 910.88M |
| Personalis | 623.88M |
| Myriad Genetics | 456.16M |